Levels of Visfatin/NAMPT in Human Milk

Recruiting now

Conditions studied: Visfatin Levels in Maternal Milk Samples, Birth Weight

In brief

Visfatin, released in maternal milk at different concentrations related to the maternal conditions, could act as a biomarker with a prognostic/predictive value to determine different newborn clinical conditions, particularly the weight loss of the neonate.

Key facts

Study ID

NCT06487286

Run by

Paolo Manzoni Study Group

People needed

30

Starts

2024-10-24

Expected to finish

2025-04-23

Last updated by the study team

2024-11-14

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Healthy male and female infants born after 37 weeks' gestation who do not have conditions related to congenital abnormalities
• Maternal hospitalization
• Acquisition of the informed consent form signed by the patient

You may not qualify if…

• Refusal of the patient to participate in the study
• Presence of hypogalactia or agalactia in the patient

Where it is running

• Ospedale degli Infermi - ASL BI — Ponderano, BI, Italy (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.